Insufficient scRNA-seq data for expression of OLIG3 at single-cell level.
Insufficient scRNA-seq data for expression of OLIG3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 57% | 3.44 | 186 / 328 | 7% | 0.16 | 12 / 178 |
kidney | 43% | 2.31 | 38 / 89 | 3% | 0.15 | 31 / 901 |
esophagus | 42% | 1.91 | 600 / 1445 | 0% | 0 | 0 / 183 |
skin | 33% | 1.53 | 606 / 1809 | 0% | 0 | 0 / 472 |
prostate | 13% | 0.61 | 33 / 245 | 9% | 0.17 | 44 / 502 |
lung | 16% | 0.24 | 94 / 578 | 3% | 0.50 | 29 / 1155 |
ovary | 13% | 0.21 | 24 / 180 | 5% | 0.49 | 23 / 430 |
peripheral blood | 16% | 0.28 | 148 / 929 | 0% | 0 | 0 / 0 |
uterus | 12% | 0.28 | 20 / 170 | 4% | 0.15 | 17 / 459 |
breast | 12% | 0.19 | 56 / 459 | 1% | 0.02 | 7 / 1118 |
stomach | 10% | 0.14 | 37 / 359 | 1% | 0.02 | 4 / 286 |
bladder | 10% | 0.29 | 2 / 21 | 2% | 0.04 | 10 / 504 |
intestine | 11% | 0.20 | 108 / 966 | 0% | 0.00 | 1 / 527 |
brain | 9% | 0.28 | 245 / 2642 | 1% | 0.03 | 6 / 705 |
adrenal gland | 10% | 0.12 | 26 / 258 | 0% | 0 | 0 / 230 |
adipose | 10% | 0.13 | 120 / 1204 | 0% | 0 | 0 / 0 |
liver | 7% | 0.09 | 16 / 226 | 2% | 0.16 | 10 / 406 |
spleen | 9% | 0.12 | 22 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 9% | 0.10 | 114 / 1335 | 0% | 0 | 0 / 0 |
heart | 8% | 0.09 | 71 / 861 | 0% | 0 | 0 / 0 |
muscle | 7% | 0.08 | 56 / 803 | 0% | 0 | 0 / 0 |
thymus | 6% | 0.07 | 41 / 653 | 0% | 0 | 0 / 605 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0021520 | Biological process | spinal cord motor neuron cell fate specification |
GO_0007423 | Biological process | sensory organ development |
GO_0061564 | Biological process | axon development |
GO_0097476 | Biological process | spinal cord motor neuron migration |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0070888 | Molecular function | E-box binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | OLIG3 |
Protein name | Oligodendrocyte transcription factor 3 (Oligo3) (Class B basic helix-loop-helix protein 7) (bHLHb7) (Class E basic helix-loop-helix protein 20) (bHLHe20) |
Synonyms | BHLHE20 BHLHB7 |
Description | FUNCTION: May determine the distinct specification program of class A neurons in the dorsal part of the spinal cord and suppress specification of class B neurons. |
Accessions | ENST00000367734.4 Q7RTU3 |